Ravi Vijayaraghavan
Board Member
Synopsys Inc (SNPS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ravi Vijayaraghavan
Ravi Vijayaraghavan is recorded as Board Member at Synopsys Inc (SNPS). Synopsys Inc reported in an 8-K filed April 20, 2026 that Ravi Vijayaraghavan was appointed Director, effective April 16, 2026. Synopsys Inc reported in an 8-K filed July 17, 2025 that Ravi Vijayaraghavan was appointed director, effective July 17, 2025.
“Synopsys' stockholders elected ten directors to the Board, to serve until the next annual meeting of stockholders and until their successors are elected and qualified or until their earlier death, resignation or removal.”
“On July 17, 2025, in accordance with the applicable provisions of Synopsys' amended and restated bylaws, the Board of Directors (the "Board") of Synopsys increased the size of the Board from nine to eleven directors and, pursuant to the Merger Agreement, appointed Dr. Ajei Gopal and Ravi Vijayaraghavan to serve as directors effective as of the Effective Time.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-04-16–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Synopsys Inc
Other people whose current roles at this company are on record from its filings.
- Chi-Foon Chan CEO, Board Member
- Sassine Ghazi CEO, Board Member
- Aart J. de Geus Chairman, Board Member
- Janet Lee General Counsel
- John F. Runkel General Counsel
- Bruce R. Chizen Board Member
- Chrysostomos L. "Max" Nikias Board Member
- Dr. Ajei Gopal Board Member
- Janice D. Chaffin Board Member
- Jeannine P. Sargent Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.